Korkalainen M K, Törrönen A R, Kärenlampi S O
Department of Biochemistry and Biotechnology, University of Kuopio, Finland.
Chem Biol Interact. 1995 Feb;94(2):121-34. doi: 10.1016/0009-2797(94)03325-3.
The mouse hepatoma cell line Hepa-1 is inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for both CYP1A1 (aryl hydrocarbon hydroxylase, AHH) and class 3 aldehyde dehydrogenase (ALDH3) enzymes. To test the hypothesis of a common regulatory mechanism, several AHH deficient mutants of Hepa-1 were studied for their ALDH3 activities and specific mRNA levels before and after TCDD treatment. The recessive (with respect to the wild-type Hepa-1) mutants have defects in Cypla-1 structural gene (mutant c1) or in the Ah (aryl hydrocarbon) receptor (mutants c2 and c6 with decreased levels of Ah receptor; mutant c4 defective in the DNA binding of the Ah receptor). The results with these mutants suggested that Ah receptor nuclear translocator protein, ARNT, is needed for ALDH3 expression. Two dominant mutants, one of which is characterized by preventing the binding of the Ah receptor complex to DNA, were also studied. Surprisingly, these mutants possessed elevated levels of ALDH3 mRNA and enzyme activities which were also inducible by TCDD. The binding of Ah receptor-ligand complex to DNA was thus not needed for the expression of ALDH3. A dominant repressor for Cypla-1 gene transcription did not prevent the derepression or induction of ALDH3. The results thus suggest that Aldh-3 gene is regulated by a mechanism independent of the Ah receptor.
小鼠肝癌细胞系Hepa-1可被2,3,7,8-四氯二苯并对二恶英(TCDD)诱导产生细胞色素P450 1A1(芳烃羟化酶,AHH)和3类醛脱氢酶(ALDH3)。为了验证共同调控机制的假说,研究了Hepa-1的几个AHH缺陷型突变体在TCDD处理前后的ALDH3活性和特异性mRNA水平。隐性(相对于野生型Hepa-1)突变体在细胞色素P450 1A1结构基因(突变体c1)或芳烃(Ah)受体(突变体c2和c6的Ah受体水平降低;突变体c4的Ah受体DNA结合缺陷)方面存在缺陷。这些突变体的结果表明,ALDH3表达需要芳烃受体核转运蛋白ARNT。还研究了两个显性突变体,其中一个的特征是阻止芳烃受体复合物与DNA结合。令人惊讶的是,这些突变体的ALDH3 mRNA水平和酶活性升高,且也可被TCDD诱导。因此,ALDH3的表达不需要芳烃受体-配体复合物与DNA结合。细胞色素P450 1A1基因转录的显性阻遏物并不能阻止ALDH3的去阻遏或诱导。因此,结果表明Aldh-3基因受一种独立于芳烃受体的机制调控。